[HTML][HTML] Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
Y Hu, J Cai, M Ye, Q Mou, B Zhao, Q Sun… - Frontiers in …, 2022 - frontiersin.org
Introduction Uveal melanoma (UM) is the most common primary intraocular malignant tumor
in adults, and the main treatment for UM is currently surgery and plaque brachytherapy. UM …
in adults, and the main treatment for UM is currently surgery and plaque brachytherapy. UM …
Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
Y Hu, J Cai, M Ye, Q Mou, B Zhao… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Uveal melanoma (UM) is the most common primary intraocular malignant tumor
in adults, and the main treatment for UM is currently surgery and plaque brachytherapy. UM …
in adults, and the main treatment for UM is currently surgery and plaque brachytherapy. UM …
[HTML][HTML] Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
Y Hu, J Cai, M Ye, Q Mou, B Zhao, Q Sun… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Methods The data of UM from the Cancer Genome Atlas (TCGA) was used as a training set
and the data from Gene Expression Omnibus (GEO) was used as a validation set. To …
and the data from Gene Expression Omnibus (GEO) was used as a validation set. To …
Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
Y Hu, J Cai, M Ye, Q Mou, B Zhao, Q Sun… - Frontiers in …, 2022 - europepmc.org
Methods The data of UM from the Cancer Genome Atlas (TCGA) was used as a training set
and the data from Gene Expression Omnibus (GEO) was used as a validation set. To …
and the data from Gene Expression Omnibus (GEO) was used as a validation set. To …
Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
Y Hu, J Cai, M Ye, Q Mou, B Zhao, Q Sun… - Frontiers in …, 2022 - europepmc.org
Methods The data of UM from the Cancer Genome Atlas (TCGA) was used as a training set
and the data from Gene Expression Omnibus (GEO) was used as a validation set. To …
and the data from Gene Expression Omnibus (GEO) was used as a validation set. To …